EQS-Adhoc: STRABAG SE: Dr. Hans Peter Haselsteiner again appointed Authorised Representative of STRABAG SE

Dr. Hans Peter Haselsteiner again appointed Authorised Representative of STRABAG SE

• Continuity at STRABAG SE ensured following the tragic loss of Klemens Haselsteiner
• Management Board to continue Strategy 2030: People. Planet. Progress.
• Succession planning for position of CEO has begun

The Management Board of STRABAG SE, with the approval of the Supervisory Board, has granted Dr. Hans Peter Haselsteiner general power of attorney with effect from today. In keeping with Klemens Haselsteiner’s vision, the Management Board will continue the far-reaching transformation process initiated under the title “Work On Progress”.

During his tenure as CEO, Dr. Hans Peter Haselsteiner grew the company into an international group. He then continued to serve the Management Board in an advisory capacity as Authorised Representative until his son Klemens Haselsteiner took office on 1 January 2020.

The foundation Haselsteiner Familien-Privatstiftung currently holds 30.7% of the shares of STRABAG SE.

The Supervisory Board has already begun deliberating on a successor for the position of CEO.

Until this position is filled, the remaining members of the Management Board will assume the responsibilities previously held by Klemens Haselsteiner. This will ensure the seamless continuation of these business areas and of the Management Board’s Strategy 2030: People. Planet. Progress.